Physician profile
James Chow
NPI 1184765257
$6,084,238.76
in general payments reported to CMS, 2019-2025
15 companies · $959K in 2025
The $959K reported for 2025 was more than what 99% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $743K · 2020: $795K · 2021: $803K · 2022: $767K · 2023: $911K · 2024: $1.1M · 2025: $959K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $2.5M · Consulting Fee: $335K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $114K · Travel and Lodging: $42K · Food and Beverage: $12K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $2,473,434.48 |
| Consulting Fee | $334,855.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $113,910.00 |
| Travel and Lodging | $42,137.38 |
| Food and Beverage | $12,399.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Microport Orthopedics INC | $4,152,835.85 | 2019-2025 | Mpo Hip System, Mpo Medial Pivot Knee |
| Smith+Nephew, INC. | $1,924,656.13 | 2019-2025 | Journey II, Real Intelligence, Navio |
| Orthosensor INC. | $3,594.95 | 2019-2020 | |
| Stryker Corporation | $1,500.21 | 2021-2025 | Mako, Motionsense Digital Goniometer, Triathlon |
| Davol INC. | $493.18 | 2022-2024 | Arista Ah Flexitip |
| Maxx Orthopedics, INC. | $332.84 | 2023 | |
| Zimmer Biomet Holdings, INC. | $284.33 | 2022-2023 | Persona |
| Next Science LLC | $139.75 | 2024 | Blastx, Xperience, Surgx |
| Biocomposites INC | $130.14 | 2024 | |
| Depuy Synthes Sales INC. | $107.26 | 2021 | |
| Theragen, INC. | $66.24 | 2023 | Kneehab Xp |
| Onkos Surgical, INC. | $48.61 | 2025 | Eleos Limb Salvage System |
| Convatec INC. | $20.40 | 2022 | |
| Vericel Corporation | $16.43 | 2024 | Maci |
| Horizon Therapeutics Plc | $12.44 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Chow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.